Medical science company GE Healthcare has been listed as a leading innovator in the application of AI to medicine.
A recently updated list of AI-enabled medical devices by the Food and Drug Administration (FDA) in the US showed that GE Healthcare had the highest number of authorizations in the country.
The company’s AI strategy is centered on addressing three of healthcare’s largest challenges: health system efficiency and access, health outcomes, and system interoperability and workflow integration. This includes software that is designed to aggregate data from multiple sources and vendors to enable clinical applications that support integrated care pathway management and holistic views of each patient. It is designed to be vendor agnostic and can include a healthcare specific AI toolkit for building and running applications.
“The future of healthcare is harnessing raw data and using it to help clinicians provide better patient care,” said Vignesh Shetty, Senior Vice President & General Manager, Edison AI & Platform, GE Healthcare. “For AI to be effective, it should be seamless and within existing workflows, while uncovering patterns that complement those generated by humans. GE Healthcare’s digital strategy is to look at AI to help clinicians achieve clinical and operational outcomes that create maximum impact for patients, providers and health systems. From big iron MRI scanners used by doctors to detect tumors on the prostate gland to mobile x-ray units in the ER or ICU that technicians use to image the lungs of COVID patients at their bedside, we are seeing a tangible impact with our AI embedded on the device where and when clinicians need it. AI is an incredible lever to tackle problems at a speed and scale that our providers are coming to expect, to help save lives and improve outcomes for millions of patients everywhere.”
Responses